NAPOS Database

Acute Porphyria Drugs

H01CC01 - Ganirelix
Propably not porphyrinogenic
PNP
Rationale
Peptide, hormone antagonist interacting with sex hormone production.
Chemical description
GnRH-antagonist (peptide). Used in assisted fertilisation for prevention of a premature LH-increase.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes H01C / H01CC or go back.
References
Tradenames
Fyremadel · Ganirelix · Orgalutran Fyremadel · Ganirelix · Orgalutran · Ovamex Astarte · Fyremadel · Ganirelix · Orgalutran Ganirelix · Orgalutran Ganirelix · Orgalutran Ganirelix · Orgalutran · Ovamex Fyremadel · Ganirelix · Orgalutran · Ovamex Fyremadel · Ganirelix · Orgalutran Fyremadel · Ganirelix Fyremadel · Ganirelix · Orgalutran · Ovamex Orgalutran Ganirelix · Orgalutran Ganirelix · Orgalutran Fyremadel · Ganirelix · Orgalutran Ganirelix · Orgalutran · Ovamex Ganirelix · Orgalutran Ganirelix · Orgalutran Ganirelix · Orgalutran Ganireliks · Ganirelix · Orgalutran Ganirelix · Orgalutran Ganirelix
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙